昭衍新药
(603127)
| 流通市值：222.56亿 | | | 总市值：264.57亿 |
| 流通股本：6.30亿 | | | 总股本：7.49亿 |
| 日期 |
超大单净流入 |
大单净流入 |
中单净流入 |
小单净流入 |
| 净额 |
净占比 |
净额 |
净占比 |
净额 |
净占比 |
净额 |
净占比 |
| 2025-09-30 | -2542.15万 | -2.90% | -5620.76万 | -6.42% | -235.49万 | -0.27% | 8398.40万 | 9.59% |
| 2025-09-29 | -2544.24万 | -2.21% | -8196.05万 | -7.12% | -2686.88万 | -2.33% | 13427.17万 | 11.66% |
| 2025-09-26 | -4689.85万 | -4.51% | -4064.17万 | -3.90% | -116.38万 | -0.11% | 8870.40万 | 8.52% |
| 2025-09-25 | 7533.36万 | 5.17% | -3619.16万 | -2.48% | -4744.87万 | -3.25% | 830.67万 | 0.57% |
| 2025-09-24 | -431.53万 | -0.46% | -2365.32万 | -2.50% | -448.69万 | -0.48% | 3245.54万 | 3.44% |
| 2025-09-23 | -11286.32万 | -7.75% | -8637.89万 | -5.93% | -1345.18万 | -0.92% | 21269.39万 | 14.61% |
| 2025-09-22 | 349.14万 | 0.31% | -3118.67万 | -2.76% | -2195.52万 | -1.94% | 4965.04万 | 4.39% |
| 2025-09-19 | -10381.86万 | -7.77% | -9363.43万 | -7.01% | 2095.90万 | 1.57% | 17649.40万 | 13.21% |
| 2025-09-18 | -153.50万 | -0.07% | -3526.87万 | -1.62% | -5439.70万 | -2.50% | 9120.07万 | 4.20% |
| 2025-09-17 | -6833.90万 | -3.78% | -4232.08万 | -2.34% | -229.97万 | -0.13% | 11295.95万 | 6.26% |